Zynerba Pharmaceuticals Inc. (ZYNE) NASDAQ
$1.32 -0.01 (-0.75%)
Market Cap: $60.85M
As of 08/17/22 10:15 AM EDT. Market open.
Zynerba Pharmaceuticals Inc. (ZYNE) NASDAQ
$1.32 -0.01 (-0.75%)
Market Cap: $60.85M
As of 08/17/22 10:15 AM EDT. Market open.
Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a ... read more
Zynerba Pharmaceuticals is the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals is committed to improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Armando Anido
Full Time Employees
26
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Armando Anido
Full Time Employees
26
CEO Compensation (Base)
$568,218
CEO Compensation (Total)
$2M
URL
Address
80 W. Lancaster Avenue, Suite 300, Pennsylvania, Devon, 19333.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$1.33
Previous Close
$1.33
Days Range
$1.30 - $1.37
52 week range
$0.84 - $4.65
Volume
158,550
Avg. Volume (30 days)
507,955
Market Cap
$60.85M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
45,753,079
Open
$1.33
Previous Close
$1.33
Days Range
$1.30 - $1.37
52 week range
$0.84 - $4.65
Volume
158,550
Avg. Volume (30 days)
507,955
Market Cap
$60.85M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
45,753,079
Open in:
Open in:
INSIDER TRANSACTIONS FOR ZYNERBA PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Sebree Terri B | President | Jul 19, 2022 | Sale | $1.10 | 8,281 | 9,109 | 367,865 | Jul 20, 2022, 04:08 PM |
| Rosenberger Brian | VP, Commercial & Business Dev. | Jul 19, 2022 | Sale | $1.10 | 4,289 | 4,718 | 107,511 | Jul 20, 2022, 04:06 PM |
| Fickenscher James E | Chief Financial Officer | Jul 19, 2022 | Sale | $1.10 | 6,013 | 6,614 | 172,505 | Jul 20, 2022, 04:05 PM |
| ANIDO ARMANDO | Chairman & CEO | Jul 19, 2022 | Sale | $1.10 | 11,899 | 13,089 | 611,688 | Jul 20, 2022, 04:05 PM |
| KISNER DANIEL L | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:53 PM |
| FEDERICI WILLIAM J | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:52 PM |
| Stephenson Pamela | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:51 PM |
| MOCH KENNETH I | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:50 PM |
| COOPER WARREN D | Director | Jun 14, 2022 | Sale | $1.01 | 40 | 40 | 28,069 | Jun 16, 2022, 09:49 PM |
| Butler John P. | Director | Jun 14, 2022 | Sale | $1.01 | 53 | 54 | 33,056 | Jun 16, 2022, 09:48 PM |
| Butler John P. | Director | Aug 22, 2018 | Buy | $6.43 | 5,000 | 32,153 | 5,000 | Aug 22, 2018, 04:39 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | Aug 06, 2018 | Buy | $5.96 | 15,000 | 89,423 | 352,512 | Aug 07, 2018, 04:32 PM |
| Hanlon Suzanne M. | Sec, VP & General Counsel | Aug 06, 2018 | Buy | $5.80 | 3,800 | 22,048 | 43,693 | Aug 07, 2018, 04:30 PM |
| Sebree Terri B | President | Aug 06, 2018 | Buy | $5.79 | 3,800 | 22,013 | 182,546 | Aug 07, 2018, 04:29 PM |
| Fickenscher James E | Chief Financial Officer | Aug 06, 2018 | Buy | $5.97 | 8,518 | 50,842 | 20,718 | Aug 07, 2018, 04:28 PM |
| RAPP MICHAEL | 10% Owner | May 30, 2018 | Buy | $10.45 | 5,885 | 61,498 | 1,500,000 | May 31, 2018, 09:26 AM |
| RAPP MICHAEL | 10% Owner | May 02, 2018 | Buy | $10.46 | 15,000 | 156,945 | 1,494,115 | May 02, 2018, 05:38 PM |
| RAPP MICHAEL | 10% Owner | Mar 22, 2018 | Buy | $9.28 | 10,000 | 92,790 | 1,479,115 | Mar 23, 2018, 09:30 AM |
| RAPP MICHAEL | 10% Owner | Jan 02, 2018 | Buy | $12.99 | 15,000 | 194,847 | 1,469,115 | Jan 03, 2018, 06:05 AM |
| RAPP MICHAEL | 10% Owner | Oct 23, 2017 | Buy | $9.94 | 25,745 | 255,795 | 1,454,115 | Oct 23, 2017, 07:25 PM |
| RAPP MICHAEL | 10% Owner | Oct 20, 2017 | Buy | $9.78 | 30,000 | 293,538 | 1,428,370 | Oct 23, 2017, 07:25 PM |
| RAPP MICHAEL | 10% Owner | Oct 19, 2017 | Buy | $9.59 | 44,255 | 424,405 | 1,398,370 | Oct 23, 2017, 07:25 PM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | May 15, 2017 | Buy | $19.57 | 1,500 | 29,355 | 337,512 | May 16, 2017, 08:50 AM |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | May 12, 2017 | Buy | $19.76 | 3,500 | 69,160 | 336,012 | May 16, 2017, 08:50 AM |
| Fickenscher James E | Chief Financial Officer | May 12, 2017 | Buy | $19.82 | 5,200 | 103,064 | 12,200 | May 16, 2017, 08:50 AM |
| RAPP MICHAEL | 10% Owner | Dec 29, 2016 | Buy | $15.85 | 10,000 | 158,500 | 1,354,115 | Dec 29, 2016, 09:54 PM |
| Fickenscher James E | Chief Financial Officer | Dec 07, 2016 | Buy | $14.03 | 4,000 | 56,120 | 7,000 | Dec 08, 2016, 02:01 PM |
| Fickenscher James E | Chief Financial Officer | Dec 06, 2016 | Buy | $14.15 | 3,000 | 42,450 | 3,000 | Dec 08, 2016, 02:01 PM |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | Aug 05, 2015 | Buy | $17.92 | 3,000 | 53,760 | 3,000 | Aug 17, 2016, 02:19 PM |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | Aug 16, 2016 | Sale | $10.53 | 3,000 | 31,590 | 0 | Aug 17, 2016, 02:19 PM |
| BARON RICHARD A | Chief Financial Officer | Sep 11, 2015 | Option Exercise | $3.98 | 15,957 | 63,509 | 15,957 | Sep 15, 2015, 01:48 PM |
| HARRISON THOMAS L | Director | Aug 10, 2015 | Buy | $14.00 | 12,500 | 175,000 | 12,500 | Aug 12, 2015, 11:48 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Sebree Terri B | President | 07/19/2022 | 9,109 |
| Rosenberger Brian | VP, Commercial & Business Dev. | 07/19/2022 | 4,718 |
| Fickenscher James E | Chief Financial Officer | 07/19/2022 | 6,614 |
| ANIDO ARMANDO | Chairman & CEO | 07/19/2022 | 13,089 |
| KISNER DANIEL L | Director | 06/14/2022 | 40 |
| FEDERICI WILLIAM J | Director | 06/14/2022 | 40 |
| Stephenson Pamela | Director | 06/14/2022 | 40 |
| MOCH KENNETH I | Director | 06/14/2022 | 40 |
| COOPER WARREN D | Director | 06/14/2022 | 40 |
| Butler John P. | Director | 06/14/2022 | 54 |
| Butler John P. | Director | 08/22/2018 | 32,153 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 08/06/2018 | 89,423 |
| Hanlon Suzanne M. | Sec, VP & General Counsel | 08/06/2018 | 22,048 |
| Sebree Terri B | President | 08/06/2018 | 22,013 |
| Fickenscher James E | Chief Financial Officer | 08/06/2018 | 50,842 |
| RAPP MICHAEL | 10% Owner | 05/30/2018 | 61,498 |
| RAPP MICHAEL | 10% Owner | 05/02/2018 | 156,945 |
| RAPP MICHAEL | 10% Owner | 03/22/2018 | 92,790 |
| RAPP MICHAEL | 10% Owner | 01/02/2018 | 194,847 |
| RAPP MICHAEL | 10% Owner | 10/23/2017 | 255,795 |
| RAPP MICHAEL | 10% Owner | 10/20/2017 | 293,538 |
| RAPP MICHAEL | 10% Owner | 10/19/2017 | 424,405 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 05/15/2017 | 29,355 |
| ANIDO ARMANDO | Chairman & Chief Exec. Officer | 05/12/2017 | 69,160 |
| Fickenscher James E | Chief Financial Officer | 05/12/2017 | 103,064 |
| RAPP MICHAEL | 10% Owner | 12/29/2016 | 158,500 |
| Fickenscher James E | Chief Financial Officer | 12/07/2016 | 56,120 |
| Fickenscher James E | Chief Financial Officer | 12/06/2016 | 42,450 |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | 08/05/2015 | 53,760 |
| Hanlon Suzanne M. | Sec, General Counsel & VP HR | 08/16/2016 | 31,590 |
| BARON RICHARD A | Chief Financial Officer | 09/11/2015 | 63,509 |
| HARRISON THOMAS L | Director | 08/10/2015 | 175,000 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Load More
Period of Report: 06/30/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2022
1.38%
1Q
12/31/2021
4.07%
2Q
09/30/2021
4.95%
3Q
06/30/2021
6.56%
4Q
03/31/2021
1.98%
5Q
Load More